Description
BSE notifies trading members that 43,04,000 new equity shares of Dr Lalchandani Labs Limited issued on rights basis are listed and permitted to trade from March 6, 2026.
Summary
BSE has notified trading members that 43,04,000 new equity shares of Dr Lalchandani Labs Limited (Scrip Code: 541299) issued on a rights basis at par are listed and permitted to trade on the Exchange with effect from Friday, March 6, 2026.
Key Points
- 43,04,000 equity shares of Rs. 10/- each issued at par on rights basis are now listed on BSE
- ISIN: INE871Z01013
- Distribution Numbers: 4333069 to 8637068
- Shares are ranking pari-passu with existing equity shares of the company
Regulatory Changes
No regulatory changes. This is a standard listing notification for newly issued securities.
Compliance Requirements
Trading members are informed that these new securities are now available for trading. No additional compliance action is required beyond standard trading procedures.
Important Dates
- Date of Allotment: March 2, 2026
- Trading Commencement Date: March 6, 2026 (Friday)
Impact Assessment
Limited market impact. The listing adds 43,04,000 new equity shares to the tradeable float of Dr Lalchandani Labs Limited via a rights issue at par value of Rs. 10/-. The new shares rank pari-passu with existing shares, meaning no differential rights or dilution concerns beyond the standard rights issue dilution already known to the market.
Impact Justification
Routine listing of new equity shares issued via rights issue for a single company; no regulatory changes or broad market impact.